Yesbeck N, Huang D, Carrico C, Madurantakam P, Yang H
Gels. 2024; 10(9).
PMID: 39330195
PMC: 11431430.
DOI: 10.3390/gels10090593.
Liu L, Li Z, Yang B, Jia X, Wang S
Biomolecules. 2024; 14(6).
PMID: 38927024
PMC: 11201556.
DOI: 10.3390/biom14060620.
Wang J, Li B, Kompella U, Yang H
MedComm Biomater Appl. 2024; 2(1).
PMID: 38562247
PMC: 10983815.
DOI: 10.1002/mba2.30.
Mehta N, Mehta S
J Ocul Pharmacol Ther. 2023; 40(1):3-12.
PMID: 38052063
PMC: 10890960.
DOI: 10.1089/jop.2023.0083.
Huang C, Shen Y, Zhao Y, Zhang Z, Gao S, Hong J
Regen Biomater. 2023; 10:rbad041.
PMID: 37303848
PMC: 10247868.
DOI: 10.1093/rb/rbad041.
Nanocarriers for the Delivery of Neuroprotective Agents in the Treatment of Ocular Neurodegenerative Diseases.
Patel C, Pande S, Sagathia V, Ranch K, Beladiya J, Boddu S
Pharmaceutics. 2023; 15(3).
PMID: 36986699
PMC: 10052766.
DOI: 10.3390/pharmaceutics15030837.
Glaucoma Treatment and Hydrogel: Current Insights and State of the Art.
Fea A, Novarese C, Caselgrandi P, Boscia G
Gels. 2022; 8(8).
PMID: 36005112
PMC: 9407420.
DOI: 10.3390/gels8080510.
DABCO-Customized Nanoemulsions: Characterization, Cell Viability and Genotoxicity in Retinal Pigmented Epithelium and Microglia Cells.
Fernandes A, Dos Santos T, Granja P, Sanchez-Lopez E, Santini A, Garcia M
Pharmaceutics. 2021; 13(10).
PMID: 34683945
PMC: 8537942.
DOI: 10.3390/pharmaceutics13101652.
A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma.
Peter M, Panonnummal R
Adv Pharm Bull. 2021; 11(3):399-413.
PMID: 34513615
PMC: 8421633.
DOI: 10.34172/apb.2021.048.
Gene Therapy in the Anterior Eye Segment.
Amador C, Shah R, Ghiam S, Kramerov A, Ljubimov A
Curr Gene Ther. 2021; 22(2):104-131.
PMID: 33902406
PMC: 8531184.
DOI: 10.2174/1566523221666210423084233.
Novel Drug Delivery Systems Fighting Glaucoma: Formulation Obstacles and Solutions.
Rahic O, Tucak A, Omerovic N, Sirbubalo M, Hindija L, Hadziabdic J
Pharmaceutics. 2020; 13(1).
PMID: 33375224
PMC: 7824381.
DOI: 10.3390/pharmaceutics13010028.
Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma.
Kompella U, Hartman R, Patil M
Prog Retin Eye Res. 2020; 82:100901.
PMID: 32891866
PMC: 8317199.
DOI: 10.1016/j.preteyeres.2020.100901.
Evolution of Nanotechnology in Delivering Drugs to Eyes, Skin and Wounds via Topical Route.
Koppa Raghu P, Bansal K, Thakor P, Bhavana V, Madan J, Rosenholm J
Pharmaceuticals (Basel). 2020; 13(8).
PMID: 32726897
PMC: 7463474.
DOI: 10.3390/ph13080167.
Drug-loaded chitosan film prepared via facile solution casting and air-drying of plain water-based chitosan solution for ocular drug delivery.
Li B, Wang J, Gui Q, Yang H
Bioact Mater. 2020; 5(3):577-583.
PMID: 32405573
PMC: 7210375.
DOI: 10.1016/j.bioactmat.2020.04.013.
Recent Advancements in Non-Invasive Formulations for Protein Drug Delivery.
Bajracharya R, Song J, Back S, Han H
Comput Struct Biotechnol J. 2020; 17:1290-1308.
PMID: 31921395
PMC: 6944732.
DOI: 10.1016/j.csbj.2019.09.004.
Drug-Conjugated Dendrimer Hydrogel Enables Sustained Drug Release via a Self-Cleaving Mechanism.
Wang J, He H, Cooper R, Gui Q, Yang H
Mol Pharm. 2019; 16(5):1874-1880.
PMID: 30974947
PMC: 10958997.
DOI: 10.1021/acs.molpharmaceut.8b01207.
Polyamidoamine Dendrimer Microgels: Hierarchical Arrangement of Dendrimers into Micrometer Domains with Expanded Structural Features for Programmable Drug Delivery and Release.
Wang J, Cooper R, He H, Li B, Yang H
Macromolecules. 2019; 51(15):6111-6118.
PMID: 30705466
PMC: 6348485.
DOI: 10.1021/acs.macromol.8b01006.
DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment.
Lancina 3rd M, Wang J, Williamson G, Yang H
Mol Pharm. 2018; 15(7):2883-2889.
PMID: 29767982
PMC: 6075655.
DOI: 10.1021/acs.molpharmaceut.8b00401.
Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis.
He H, Yuan Q, Bie J, Wallace R, Yannie P, Wang J
Transl Res. 2017; 193:13-30.
PMID: 29172034
PMC: 6198660.
DOI: 10.1016/j.trsl.2017.10.008.
Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery.
Lancina 3rd M, Singh S, Kompella U, Husain S, Yang H
ACS Biomater Sci Eng. 2017; 3(8):1861-1868.
PMID: 29152562
PMC: 5685521.
DOI: 10.1021/acsbiomaterials.7b00319.